Arnott, C., Punnia-Moorthy, G., Tan, J., Sadeghipour, S., Bursill, C., & Patel, S. (2016). The Vascular Endothelial Growth Factor Inhibitors Ranibizumab and Aflibercept Markedly Increase Expression of Atherosclerosis-Associated Inflammatory Mediators on Vascular Endothelial Cells. PLoS One.
Citação norma ChicagoArnott, Clare, Gaya Punnia-Moorthy, Joanne Tan, Sara Sadeghipour, Christina Bursill, and Sanjay Patel. "The Vascular Endothelial Growth Factor Inhibitors Ranibizumab and Aflibercept Markedly Increase Expression of Atherosclerosis-Associated Inflammatory Mediators On Vascular Endothelial Cells." PLoS One 2016.
MLA citiranjeArnott, Clare, et al. "The Vascular Endothelial Growth Factor Inhibitors Ranibizumab and Aflibercept Markedly Increase Expression of Atherosclerosis-Associated Inflammatory Mediators On Vascular Endothelial Cells." PLoS One 2016.